- Home
- WLDS vs INM Comparison
WLDS vs INM Comparison
Compare WLDS & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDS
- INM
- Stock Information
- Founded
- WLDS 2014
- INM 1981
- Country
- WLDS Israel
- INM Canada
- Employees
- WLDS N/A
- INM N/A
- Industry
- WLDS Computer Communications Equipment
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- WLDS Telecommunications
- INM Health Care
- Exchange
- WLDS Nasdaq
- INM Nasdaq
- Market Cap
- WLDS 3.4M
- INM 3.2M
- IPO Year
- WLDS 2022
- INM N/A
- Fundamental
- Price
- WLDS $1.57
- INM $2.66
- Analyst Decision
- WLDS
- INM
- Analyst Count
- WLDS 0
- INM 0
- Target Price
- WLDS N/A
- INM N/A
- AVG Volume (30 Days)
- WLDS 440.9K
- INM 5.8M
- Earning Date
- WLDS 01-01-0001
- INM 05-12-2025
- Dividend Yield
- WLDS N/A
- INM N/A
- EPS Growth
- WLDS N/A
- INM N/A
- EPS
- WLDS N/A
- INM N/A
- Revenue
- WLDS $522,000.00
- INM $4,920,990.00
- Revenue This Year
- WLDS N/A
- INM N/A
- Revenue Next Year
- WLDS N/A
- INM N/A
- P/E Ratio
- WLDS N/A
- INM N/A
- Revenue Growth
- WLDS 536.59
- INM N/A
- 52 Week Low
- WLDS $1.20
- INM $1.72
- 52 Week High
- WLDS $38.80
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- WLDS 50.45
- INM 45.77
- Support Level
- WLDS $1.53
- INM $2.69
- Resistance Level
- WLDS $1.61
- INM $3.28
- Average True Range (ATR)
- WLDS 0.07
- INM 0.20
- MACD
- WLDS 0.01
- INM -0.05
- Stochastic Oscillator
- WLDS 65.00
- INM 9.81
About WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.